George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,000 shares at $617.00 ($2.5M) on 2022-02-28, disclosed to the SEC on 2022-03-01.
Open-market sale of $2.5M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $621.00 | 2,000 | $1.2M | 50.2% |
| 2 | $614.00 | 1,000 | $614K | 24.8% |
| 3 | $617.00 | 1,000 | $617K | 24.9% |
| Total | $618.25 avg | 4,000 | $2.5M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |
| REGN | SELL | 2021-11-18 | $7.0M | — | Filing → |